- Fellowship - University of Wisconsin Health Sciences Center (2015-2018), Hematology Oncology
- Residency - Indiana University School of Medicine (2010-2013), Internal Medicine
- Residency - Alshami Hospital, Syria (2009-2010), Internal Medicine
- Medical School - Damascus University School of Medicine, Syria (2002-2009)
![Waddah Arafat, M.D.](https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/original_images/arafat-waddah-183526-400x400.jpg)
Waddah Arafat, M.D.
- Internal Medicine - Hematology/Oncology
- Bladder Cancer
- Prostate Cancer
New Patient Appointment Accepting Virtual Visits or 214-645-4673
Biography
Waddah Arafat, M.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, where he also serves as Medical Director of the Clinical Cancer Informatics Program at Harold C. Simmons Comprehensive Cancer Center. He specializes in genitourinary oncology and is an expert in treating prostate, bladder, kidney, testicular, and penile cancers, as well as rare tumors such as adrenocortical carcinoma. He leads Simmons Cancer Center’s germ cell tumor board and serves as the site principal investigator on high-profile clinical trials involving urothelial cancer.
Dr. Arafat earned his medical degree at the Damascus University Faculty of Medicine in Syria and completed his residency in internal medicine at the Indiana University School of Medicine. He then received advanced training in hematology and oncology through a fellowship at the University of Wisconsin School of Medicine.
Certified by the American Board of Internal Medicine, Dr. Arafat joined the UT Southwestern faculty in 2018. He is an active member of several professional organizations, including the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research.
Dr. Arafat's research focuses on developing novel therapeutic strategies and utilizing new biomarkers to improve clinical outcomes for patients with genitourinary malignancies. His contributions to both basic and clinical research have been published in numerous academic articles.
Among many other honors and awards, Dr. Arafat was named a Texas Monthly Super Doctors “Rising Star” in 2020.
Education & Training
Honors & Awards
- Texas Monthly Super Doctors, Rising Star 2020
- Fellow Award 2017, Wisconsin Association of Hematology and Oncology
Books & Publications
-
Publications
-
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma.
Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R, Advances in radiation oncology 2021 Sep-Oct 6 5 100692 -
Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.
Tevaarwerk AJ, Chandereng T, Osterman T, Arafat W, Smerage J, Polubriaginof FCG, Heinrichs T, Sugalski J, Martin DB, JCO oncology practice 2021 Jul OP2100195 -
Disparities in Pre-Orchiectomy Sperm Cryopreservation Among Testicular Cancer Patients at a Public Safety Net Hospital and a Private Tertiary Care Center.
Patel A, Howard JM, Chertack N, Badia RR, Margulis V, Woldu SL, Courtney K, Bowman IA, Arafat W, Meng X, Bakare T, Bagrodia A, Urology 2021 Jul -
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma.
Bade RM, Schehr JL, Emamekhoo H, Gibbs BK, Rodems TS, Mannino MC, Desotelle JA, Heninger E, Stahlfeld CN, Sperger JM, Singh A, Wolfe SK, Niles DJ, Arafat W, Steinharter JA, Jason Abel E, Beebe DJ, Wei XX, McKay RR, Choueri TK, Lang JM, Molecular oncology 2021 Feb -
Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer.
Meng X, Ahmed M, Courtney KD, Arafat W, Ibrahim I, Margulis V, Nichols C, Bagrodia A, Frontiers in oncology 2021 11 724682 -
Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.
Hannan, R, Christensen, M, Robles,L, Christie, A, Garant,A, Desai, NB, Hammers, HJ, Arafat, W, Bowman, IA, Cole, S, Courtney, KD, Woldu, SL, Bagrodia, A, Margulis, V, Cadeddu, JA, Choy, H, Sher, D, Brugarolas J, Journal of Clinical Oncology 2021 39(6_suppl) p. 311-311. -
Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital.
Chertack N, Ghandour RA, Singla N, Freifeld Y, Hutchinson RC, Courtney K, Bowman IA, Arafat W, Meng X, Moore JA, Aydin AM, Sagalowsky AI, Margulis V, Lotan Y, Woldu SL, Bagrodia A, Cancer 2020 10 126 19 4362-4370 -
Prospective Safety and Feasibility trial of Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC)
S.All, A.Diaz de Leon, O.Mohamad, H.Choy, H.Hammers, A.Sanjeevaiah, W.Arafat, K.Courtney, R.D.Timmermanm J.Brugarolas, R.Hannan International Journal of Radiation Oncology, Biology, Physics 2020 108 3, suppl_1 e896-e897 -
Intra-patient heterogeneity in urothelial cancer (UC) circulating tumor cells (CTC) and PDL1 expression to identify biomarkers of response and new therapeutic targets: A pilot study.
Arafat, W, Stahlfeld, C, Sperger, JM, Heninger, E, Gopalakrishnan, D, Barata, PC, Lamenza, M, Devonshire, S, Hoxha, N, Profusek, P, Rini, Bi, Ornstein, MC, Garcia, JA, Kyriakopoulos, C, Lang, JM, Grivas, P Journal of Clinical Oncology 2017 35, no. 15_suppl -
Development and clinical validation of circulating tumor cell (CTC) biomarkers in clear cell renal cell carcinoma (ccRCC) for the OMNIVORE clinical trial.
Arafat, W, Desotelle, J, Rodems, T, McKay, RR, Abel, J, Choueiri, TK, Lang, JM Journal of Clinical Oncology 2017 35, no. 15_suppl p. 4579-4579. -
Inferior Vena Cava Filter - Appropriate Use and Retrieval
Shah, R, Turk, A, Rahim, B, Arafat, W, Nazeef, M, Mattison, RJ Blood 2016 128(22) p. 5912-5912. -
Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature.
Arafat W, Albany C, Ulbright TM, Foster R, Einhorn LH Journal of surgical case reports 2014 Jun 2014 6
-
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma.
Clinical Focus
- Bladder Cancer
- Prostate Cancer
- Testicular Cancer
- Kidney Cancer
Results: 1 Locations
Genitourinary Cancer Clinic
at Cancer Care Outpatient Building 6202 Harry Hines Blvd., 9th FloorDallas, Texas 75235 (214) 645-4673 Directions to Genitourinary Cancer Clinic Parking Info for Genitourinary Cancer Clinic
New Patient Appointment Accepting Virtual Visits or 214-645-4673